NeuroOne Medical Technologies Corp

NeuroOne Medical Technologies Corp. is a medical technology company, which engages in the development and commercialization of thin film electrode technology for continuous electroencephalogram and stereoelectrocencephalography recording, spinal cord stimulation, brain stimulation, and ablation solutions. The company was founded by Mark Christianson on August 20, 2009 and is headquartered in Eden Prairie, MN.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

NeuroOne Medical Technologies Corp excels in Q2 2024 performance

NeuroOne Medical Technologies Corp demonstrated strong commercial and financial performance in Q2 2024.
The company's focus on innovation, strategic partnerships, and diverse product development is driving growth.
While facing challenges in capital management and market competition, NeuroOne is well-positioned for future success.
Opportunities in product diversification, market expansion, and fundraising set the stage for continued growth and profitability.

NeuroOne Medical Technologies Corp reports strong Q3 performance and expansion opportunities

NMTC's Q3 2024 performance reflects progress in commercialization and product revenue growth, supported by strategic financing initiatives.
While facing challenges in managing expenses and achieving profitability, the company is well-positioned to capitalize on distribution agreements and product expansion.
With a focus on innovation and market penetration, NMTC is poised for growth through new FDA applications and leveraging its technological advancements.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

EDEN PRAIRIE, Minn., July 7, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC; NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today that the company will present at Access to Giving Virtual Conference.

NeuroOne to Present at Access to Giving Virtual Conference on July 15, 2021 at 2 p.m. ET

EDEN PRAIRIE, Minn., June 2, 2021 /PRNewswire/ --  NeuroOne Medical Technologies Corporation  (NASDAQ: NMTC; NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today the formation of a six member advisory board of leading neurosurgeons to assist in the completion of development of a radio frequency ablation electrode intended to record and ablate brain tissue linked to causing seizure activity.

NeuroOne Introduces Advisory Board for Ablation Electrode Technology that Records and Ablates Brain Tissue Linked to Seizure Activity

EDEN PRAIRIE, Minn., May 25, 2021 /PRNewswire/ --  NeuroOne Medical Technologies Corporation  (OTCQB: NMTC; NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today it has been approved to uplist to The Nasdaq Capital Market.

NeuroOne Announces Approval for Nasdaq Capital Market Listing; Trading Expected to Commence Tomorrow May 26th, 2021 Under the Symbol NMTC

News for NeuroOne Medical Technologies Corp Stock (NMTC)